Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Antifungal therapy with voriconazole or amphotericin B may be an effective
treatment for aspergillosis. It is not yet known whether voriconazole is more effective than
amphotericin B in treating patients with aspergillosis.
PURPOSE: Randomized phase III trial to compare the effectiveness of voriconazole with
amphotericin B in treating patients with aspergillosis.
Phase:
Phase 3
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Treatments:
Amphotericin B Amphotericin B, deoxycholate drug combination Deoxycholic Acid Liposomal amphotericin B Voriconazole